Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Non-Current Deffered Revenue (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $462000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Non-Current Deffered Revenue fell 63.99% year-over-year to $462000.0, compared with a TTM value of $462000.0 through Mar 2025, down 63.99%, and an annual FY2024 reading of $3.8 million, up 180.61% over the prior year.
  • Non-Current Deffered Revenue was $462000.0 for Q1 2025 at BrightSpring Health Services, down from $3.8 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $3.8 million in Q4 2024 and bottomed at $462000.0 in Q1 2025.
  • Average Non-Current Deffered Revenue over 3 years is $1.7 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Non-Current Deffered Revenue skyrocketed 180.61% in 2024, then crashed 63.99% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $1.3 million in 2023, then surged by 180.61% to $3.8 million in 2024, then tumbled by 87.77% to $462000.0 in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for BTSG at $462000.0 in Q1 2025, $3.8 million in Q4 2024, and $1.3 million in Q1 2024.